Allogene Therapeutics, Inc. Short-term Lease Commitment, Amount
Allogene Therapeutics, Inc. (ALLO) had Short-term Lease Commitment, Amount of $0 as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:ShortTermLeaseCommitmentAmount · last filed 2020-02-27
- 2019-12-31: Short-term Lease Commitment, Amount $0.00.
- 2019-06-30: Short-term Lease Commitment, Amount $400.00K.
- 2019-03-31: Short-term Lease Commitment, Amount $700.00K.
- 2018-12-31: Short-term Lease Commitment, Amount $1.60M.
| Period end | Short-term Lease Commitment, Amount |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $700.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.60M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |